The Board

Dr Dale Athey, Chief Executive Officer - leads and manages the business overall. A co-founder of Orla with Jeremy Lakey, Dale has 20 years experience in clinical diagnostics, including extensive commercial experience in customer-facing roles with global companies such as Bayer and Chiron Diagnostics.

Dr Frank Roberts, Non-Executive Chairman - over 20 years of management and leadership experience in the bioprocess and bioscience industries. Frank established and managed the biotechnology company, Bioprocessing Limited, growing it from start-up, pre-revenue stage through to profitability and ultimate sale to Millipore for $20M in 1999.

Prof Jeremy Lakey, Scientific Director - leads Orla's scientific strategy, focusing on R&D that develops Orla's overall business strategy and responds to specific customer requirements. Professor of Structural Biochemistry, University of Newcastle upon Tyne, UK and a former BBSRC Research Development Fellow, Jeremy is a world-renowned expert on proteins, which emphasises the credibility of Orla's technology and provides the company with continued technology streams.

Barrie Hensby, Non Executive Director - is the chief executive of NEL Fund Managers Ltd, a Venture Capital company based in the North East of England, with £70m under management. Barrie has over twenty years of experience as a company director in a wide variety of companies.